Chidamide and apatinib are therapeutically synergistic in acute myeloid leukemia stem and progenitor cells
Abstract Background Leukemia stem cells (LSCs) are responsible for the initiation and perpetuation of acute myeloid leukemia (AML), and also represent leukemia relapse reservoirs with limited therapeutic approaches. Thus, additional treatment strategies are medical unmet needs to eliminate LSCs. Met...
Сохранить в:
| Главные авторы: | , , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BMC
2022-05-01
|
| Серии: | Experimental Hematology & Oncology |
| Предметы: | |
| Online-ссылка: | https://doi.org/10.1186/s40164-022-00282-1 |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|